- All sections
- G - Physics
- G01N - Investigating or analysing materials by determining their chemical or physical properties
- G01N 33/573 - ImmunoassayBiospecific binding assayMaterials therefor for enzymes or isoenzymes
Patent holdings for IPC class G01N 33/573
Total number of patents in this class: 2486
10-year publication summary
|
246
|
170
|
169
|
175
|
146
|
158
|
138
|
137
|
158
|
138
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| aTyr Pharma, Inc. | 161 |
51 |
| Pangu BioPharma Limited | 106 |
50 |
| The Regents of the University of California | 20035 |
45 |
| The Johns Hopkins University | 5700 |
34 |
| Takeda Pharmaceutical Company Limited | 2707 |
28 |
| Genentech, Inc. | 3988 |
19 |
| Abbott Laboratories | 2397 |
19 |
| Centre National de La Recherche Scientifique | 10498 |
17 |
| Board of Regents, The University of Texas System | 5841 |
16 |
| Promega Corporation | 576 |
16 |
| Massachusetts Institute of Technology | 10093 |
15 |
| National Research Council of Canada | 1547 |
14 |
| Dana-Farber Cancer Institute, Inc. | 2577 |
13 |
| Yale University | 2400 |
13 |
| California Institute of Technology | 3988 |
12 |
| The University of Tokyo | 4202 |
12 |
| President and Fellows of Harvard College | 5992 |
11 |
| Mayo Foundation for Medical Education and Research | 3232 |
11 |
| Astute Medical, Inc. | 110 |
11 |
| City of Hope | 996 |
11 |
| Other owners | 2068 |